Acerus Pharmaceuticals (FRA:3TP0) COGS-to-Revenue : 0.26 (As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Acerus Pharmaceuticals COGS-to-Revenue?

Acerus Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2022 was €0.20 Mil. Its Revenue for the three months ended in Sep. 2022 was €0.78 Mil.

Acerus Pharmaceuticals's COGS to Revenue for the three months ended in Sep. 2022 was 0.26.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Acerus Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2022 was 73.78%.

Acerus Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Acerus Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals COGS-to-Revenue Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

0.50

1.40

0.58

1.86

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
COGS-to-Revenue	Get a 7-Day Free Trial															0.83	0.53	0.32	0.64	0.26

Acerus Pharmaceuticals COGS-to-Revenue Calculation

Acerus Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.989	/	-3.658
	=

Acerus Pharmaceuticals's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.204	/	0.778
	=	0.26

Acerus Pharmaceuticals (FRA:3TP0) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Acerus Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.204 / 0.778
	=	73.78 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Acerus Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Acerus Pharmaceuticals (FRA:3TP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (FRA:3TP0) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus Pharmaceuticals (FRA:3TP0) Headlines

No Headlines